Literature DB >> 26179431

Polymyxin B haemoperfusion in septic shock patients.

Nobuaki Shime1, Graeme MacLaren2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26179431     DOI： 10.1007/s00134-015-3971-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection.

Authors:  Jean-Louis Vincent; Pierre-François Laterre; Jonathan Cohen; Hilmar Burchardi; Hajo Bruining; Francisco Alvarez Lerma; Xavier Wittebole; Daniel De Backer; Stephen Brett; Dolores Marzo; Haruji Nakamura; Stephanie John
Journal:  Shock       Date:  2005-05       Impact factor: 3.454

2.  Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.

Authors:  Dinna N Cruz; Massimo Antonelli; Roberto Fumagalli; Francesca Foltran; Nicola Brienza; Abele Donati; Vincenzo Malcangi; Flavia Petrini; Giada Volta; Franco M Bobbio Pallavicini; Federica Rottoli; Francesco Giunta; Claudio Ronco
Journal:  JAMA       Date:  2009-06-17       Impact factor: 56.272

3.  Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.

Authors:  Didier M Payen; Joelle Guilhot; Yoann Launey; Anne Claire Lukaszewicz; Mahmoud Kaaki; Benoit Veber; Julien Pottecher; Olivier Joannes-Boyau; Laurent Martin-Lefevre; Matthieu Jabaudon; Olivier Mimoz; Rémi Coudroy; Martine Ferrandière; Eric Kipnis; Carlos Vela; Stéphanie Chevallier; Jihad Mallat; René Robert
Journal:  Intensive Care Med       Date:  2015-04-11       Impact factor: 17.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.